These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8725950)

  • 1. Studying interactions involving the T-cell antigen receptor by surface plasmon resonance.
    Margulies DH; Plaksin D; Khilko SN; Jelonek MT
    Curr Opin Immunol; 1996 Apr; 8(2):262-70. PubMed ID: 8725950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity and kinetics of the interactions between an alphabeta T-cell receptor and its superantigen and class II-MHC/peptide ligands.
    Khandekar SS; Brauer PP; Naylor JW; Chang HC; Kern P; Newcomb JR; Leclair KP; Stump HS; Bettencourt BM; Kawasaki E; Banerji J; Profy AT; Jones B
    Mol Immunol; 1997 Apr; 34(6):493-503. PubMed ID: 9307065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring interactions of MHC class I molecules using surface plasmon resonance.
    Khilko SN; Jelonek MT; Corr M; Boyd LF; Bothwell AL; Margulies DH
    J Immunol Methods; 1995 Jun; 183(1):77-94. PubMed ID: 7602142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity.
    Corr M; Slanetz AE; Boyd LF; Jelonek MT; Khilko S; al-Ramadi BK; Kim YS; Maher SE; Bothwell AL; Margulies DH
    Science; 1994 Aug; 265(5174):946-9. PubMed ID: 8052850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.
    Matsui K; Boniface JJ; Steffner P; Reay PA; Davis MM
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12862-6. PubMed ID: 7809136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
    Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC
    Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.
    De Oliveira DB; Harfouch-Hammoud E; Otto H; Papandreou NA; Stern LJ; Cohen H; Boehm BO; Bach J; Caillat-Zucman S; Walk T; Jung G; Eliopoulos E; Papadopoulos GK; van Endert PM
    Mol Immunol; 2000 Oct; 37(14):813-25. PubMed ID: 11257303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of MHC-CD8 interaction at the T cell membrane.
    Huang J; Edwards LJ; Evavold BD; Zhu C
    J Immunol; 2007 Dec; 179(11):7653-62. PubMed ID: 18025211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
    Bhayani H; Paterson Y
    J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-step binding mechanism for T-cell receptor recognition of peptide MHC.
    Wu LC; Tuot DS; Lyons DS; Garcia KC; Davis MM
    Nature; 2002 Aug; 418(6897):552-6. PubMed ID: 12152083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cytosolic tail dependence and intracellular fate of T-cell receptors internalized upon activation with superantigen or phorbol ester.
    Niedergang F; San José E; Rubin B; Alarcón B; Dautry-Varsat A; Alcover A
    Res Immunol; 1997 May; 148(4):231-45. PubMed ID: 9300530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex.
    Beringer DX; Kleijwegt FS; Wiede F; van der Slik AR; Loh KL; Petersen J; Dudek NL; Duinkerken G; Laban S; Joosten A; Vivian JP; Chen Z; Uldrich AP; Godfrey DI; McCluskey J; Price DA; Radford KJ; Purcell AW; Nikolic T; Reid HH; Tiganis T; Roep BO; Rossjohn J
    Nat Immunol; 2015 Nov; 16(11):1153-61. PubMed ID: 26437244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling of a T-cell receptor bound to a major histocompatibility complex molecule: implications for T-cell recognition.
    Almagro JC; Vargas-Madrazo E; Lara-Ochoa F; Horjales E
    Protein Sci; 1995 Sep; 4(9):1708-17. PubMed ID: 8528069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
    von Bonin A; Ehrlich S; Malcherek G; Fleischer B
    Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein.
    Gascoigne NR; Ames KT
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):613-6. PubMed ID: 1824876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
    Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
    J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class II-dependent peptide antigen versus superantigen presentation to T cells.
    Shoukry NH; Lavoie PM; Thibodeau J; D'Souza S; Sekaly RP
    Hum Immunol; 1997 May; 54(2):194-201. PubMed ID: 9297538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.